Moderna expects 2025 revenue of $1.9B, above guidance — Neutral

MRNA   Proactive Investors — January 12, 2026

Moderna Inc (NASDAQ:MRNA, XETRA:0QF) said it expects 2025 revenue of approximately $1.9 billion, about $100 million above the midpoint of its previously communicated guidance of $1.6 to $2 billion. The company also raised its 2025 GAAP operating expense outlook by $200 million to a range of $5 to $5.2 billion and projects a year-end cash balance of approximately $8.1 billion, including a $0.6 billion drawdown from a recently announced $1.5 billion term loan facility.

image for news Moderna expects 2025 revenue of $1.9B, above guidance

Harrow: Flirting With Missing 2025 Revised Guidance — Negative

HROW   Seeking Alpha — January 12, 2026

Harrow may deliver $265M in 2025 revenue, potentially missing the low end of its revised $270M–$280M guidance. Recent Bloomberg data suggest strong growth in Iheezo and Vevye, but specialty and compounded segments face headwinds and one-time impacts. Considerable uncertainty exists due to data limitations and ASP uncertainty.

image for news Harrow: Flirting With Missing 2025 Revised Guidance

Paramount says it is suing Warner Bros. Discovery and filing a competing slate of directors in an effort to get the Warner board to take its offer to acquire the company seriously.

image for news Show us the math: Paramount sues Warner Bros. over how it determined Netflix's bid is better

Eli Lilly and Nvidia Make $1 Billion AI Bet to Revolutionize Pharma's Future — Neutral

LLY  NVDA   24/7 Wall Street — January 12, 2026

One of the major promises of artificial intelligence (AI) is its role in speeding up drug discovery.

image for news Eli Lilly and Nvidia Make $1 Billion AI Bet to Revolutionize Pharma's Future

PepsiCo's PFNA Struggles: Can Permissible Snacks Revive Volumes? — Negative

PEP   Zacks Investment Research — January 12, 2026

PEP is leaning on permissible snack brands to counter uneven PFNA volumes as value sensitivity and shifting preferences pressure core snacks.

image for news PepsiCo's PFNA Struggles: Can Permissible Snacks Revive Volumes?

Why HUT 8 Stock Is a Sell Even After a 171% Surge in 6 Months — Negative

HUT   Zacks Investment Research — January 12, 2026

After a 171% six-month rally, HUT faces downside as heavy Bitcoin exposure, power constraints and a stretched valuation limit upside.

image for news Why HUT 8 Stock Is a Sell Even After a 171% Surge in 6 Months

Toronto-Dominion Bank (TD) Could Be a Great Choice — Positive

TD   Zacks Investment Research — January 12, 2026

Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Toronto-Dominion (TD) have what it takes?

image for news Toronto-Dominion Bank (TD) Could Be a Great Choice

Can Amazon Stock Hit $300? — Positive

AMZN   Forbes — January 12, 2026

While Amazon stock (NASDAQ: AMZN) gained 5% in 2025, the stock notably underperformed the broader S&P 500, which climbed 16% over the same period. However, momentum has shifted in 2026; the stock has seen a strong start to the year, rising 7% year-to-date.

image for news Can Amazon Stock Hit $300?

Paramount accused WBD's board of breaching fiduciary duties by refusing to engage with what it calls a financially superior proposal.

image for news Paramount escalates hostile bid for Warner Bros. Discovery with proxy fight, lawsuit

Gold and silver surged to fresh record highs Monday as investors reassessed the Federal Reserve's independence fears amid a new political escalation.

image for news Gold, Silver Spike To Record Highs As Fed Independence Falters: What's Moving Markets Monday?

Topgolf's Leverage Declines: How Is Financial Flexibility Shaping Up? — Positive

MODG   Zacks Investment Research — January 12, 2026

MODG strengthens its balance sheet in Q3 2025, boosting liquidity and cutting leverage as cash flow improves.

image for news Topgolf's Leverage Declines: How Is Financial Flexibility Shaping Up?

ARCO vs. CAVA: Which Stock Is the Better Value Option? — Positive

ARCO  CAVA   Zacks Investment Research — January 12, 2026

Investors interested in stocks from the Retail - Restaurants sector have probably already heard of Arcos Dorados (ARCO) and Cava Group (CAVA). But which of these two stocks is more attractive to value investors?

image for news ARCO vs. CAVA: Which Stock Is the Better Value Option?

HSTM vs. SHOP: Which Stock Is the Better Value Option? — Positive

HSTM  SHOP   Zacks Investment Research — January 12, 2026

Investors interested in stocks from the Internet - Services sector have probably already heard of HealthStream (HSTM) and Shopify (SHOP). But which of these two stocks presents investors with the better value opportunity right now?

image for news HSTM vs. SHOP: Which Stock Is the Better Value Option?

TD vs. IBN: Which Stock Should Value Investors Buy Now? — Positive

IBN  TD   Zacks Investment Research — January 12, 2026

Investors with an interest in Banks - Foreign stocks have likely encountered both Toronto-Dominion Bank (TD) and ICICI Bank Limited (IBN). But which of these two stocks is more attractive to value investors?

image for news TD vs. IBN: Which Stock Should Value Investors Buy Now?

KHNGY or CHRW: Which Is the Better Value Stock Right Now? — Neutral

CHRW   Zacks Investment Research — January 12, 2026

Investors interested in Transportation - Services stocks are likely familiar with Kuehne & Nagel International Ag (KHNGY) and C.H. Robinson Worldwide (CHRW).

image for news KHNGY or CHRW: Which Is the Better Value Stock Right Now?

CLPBY vs. PEN: Which Stock Is the Better Value Option? — Neutral

CLPBY  PEN   Zacks Investment Research — January 12, 2026

Investors with an interest in Medical - Instruments stocks have likely encountered both Coloplast A/S Sponsored ADR (CLPBY) and Penumbra (PEN). But which of these two stocks offers value investors a better bang for their buck right now?

image for news CLPBY vs. PEN: Which Stock Is the Better Value Option?

FTRE vs. ACAD: Which Stock Is the Better Value Option? — Positive

ACAD  FTRE   Zacks Investment Research — January 12, 2026

Investors looking for stocks in the Medical - Biomedical and Genetics sector might want to consider either Fortrea Holdings Inc. (FTRE) or Acadia Pharmaceuticals (ACAD). But which of these two companies is the best option for those looking for undervalued stocks?

image for news FTRE vs. ACAD: Which Stock Is the Better Value Option?

COO or WST: Which Is the Better Value Stock Right Now? — Neutral

COO  WST   Zacks Investment Research — January 12, 2026

Investors looking for stocks in the Medical - Dental Supplies sector might want to consider either The Cooper Companies (COO) or West Pharmaceutical Services (WST). But which of these two stocks is more attractive to value investors?

image for news COO or WST: Which Is the Better Value Stock Right Now?

MWA vs. NDSN: Which Stock Is the Better Value Option? — Neutral

MWA  NDSN   Zacks Investment Research — January 12, 2026

Investors looking for stocks in the Manufacturing - General Industrial sector might want to consider either Mueller Water Products (MWA) or Nordson (NDSN). But which of these two stocks offers value investors a better bang for their buck right now?

image for news MWA vs. NDSN: Which Stock Is the Better Value Option?

DG or ROST: Which Is the Better Value Stock Right Now? — Neutral

DG  ROST   Zacks Investment Research — January 12, 2026

Investors interested in Retail - Discount Stores stocks are likely familiar with Dollar General (DG) and Ross Stores (ROST). But which of these two stocks offers value investors a better bang for their buck right now?

image for news DG or ROST: Which Is the Better Value Stock Right Now?